Microba Life Sciences agree to merge in all-stock deal

SYDNEY:  Genetic Signatures Limited and Microba Life Sciences Limited announced Tuesday they have agreed to principal commercial terms for a merger that would create a combined Australian diagnostics company with about $29.6 million in aggregate annual revenue. The proposed merger, implemented through a scheme of…